WallStreetZenWallStreetZen

NASDAQ: INBX
Inhibrx Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their INBX stock forecasts and price targets.

Forecast return on equity

Is INBX forecast to generate an efficient return?

Company
-45.92%
Industry
259.27%
Market
228.52%
INBX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is INBX forecast to generate an efficient return on assets?

Company
-9.53%
Industry
90.14%
INBX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INBX earnings per share forecast

What is INBX's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$9.19
Avg 2 year Forecast
-$4.85
Avg 3 year Forecast
-$2.81

INBX revenue forecast

What is INBX's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$1.3M-5.29%
Avg 2 year Forecast
$4.4M+213.29%
Avg 3 year Forecast
$99.6M+7,014%
INBX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

INBX revenue growth forecast

How is INBX forecast to perform vs Biotechnology companies and vs the US market?

Company
291.86%
Industry
102.02%
Market
25.67%
INBX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
INBX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

INBX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INBX$89.47N/AN/A
TNGX$9.63$12.40+28.76%Strong Buy
ELVN$21.81$45.67+109.39%Strong Buy
KOD$24.34$22.67-6.87%Buy
FTRE$14.24$10.70-24.86%Hold
View Top Biotech Stocks

Inhibrx Biosciences Stock Forecast FAQ

What is INBX's earnings growth forecast for 2025-2027?

(NASDAQ: INBX) Inhibrx Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 44.75%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.88%.

Inhibrx Biosciences's earnings in 2025 is -$155,086,000.On average, 3 Wall Street analysts forecast INBX's earnings for 2025 to be -$133,614,775, with the lowest INBX earnings forecast at -$128,376,121, and the highest INBX earnings forecast at -$137,545,948. On average, 3 Wall Street analysts forecast INBX's earnings for 2026 to be -$70,583,669, with the lowest INBX earnings forecast at -$67,814,542, and the highest INBX earnings forecast at -$72,659,061.

In 2027, INBX is forecast to generate -$40,795,185 in earnings, with the lowest earnings forecast at -$39,195,374 and the highest earnings forecast at -$41,995,043.

If you're new to stock investing, here's how to buy Inhibrx Biosciences stock.

What is INBX's revenue growth forecast for 2025-2028?

(NASDAQ: INBX) Inhibrx Biosciences's forecast annual revenue growth rate of 291.86% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 102.02%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.67%.

Inhibrx Biosciences's revenue in 2025 is $1,400,000.On average, 3 Wall Street analysts forecast INBX's revenue for 2025 to be $19,284,997, with the lowest INBX revenue forecast at $18,528,722, and the highest INBX revenue forecast at $19,852,202. On average, 3 Wall Street analysts forecast INBX's revenue for 2026 to be $63,788,835, with the lowest INBX revenue forecast at $61,287,312, and the highest INBX revenue forecast at $65,664,977.

In 2028, INBX is forecast to generate $1,448,498,130 in revenue, with the lowest revenue forecast at $1,391,690,289 and the highest revenue forecast at $1,491,169,457.

What is INBX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: INBX) forecast ROA is -9.53%, which is lower than the forecast US Biotechnology industry average of 90.14%.

What is INBX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: INBX) Inhibrx Biosciences's current Earnings Per Share (EPS) is -$11.96. On average, analysts forecast that INBX's EPS will be -$9.19 for 2025, with the lowest EPS forecast at -$8.83, and the highest EPS forecast at -$9.46. On average, analysts forecast that INBX's EPS will be -$4.85 for 2026, with the lowest EPS forecast at -$4.66, and the highest EPS forecast at -$5.00. In 2027, INBX's EPS is forecast to hit -$2.81 (min: -$2.70, max: -$2.89).

What is INBX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: INBX) forecast ROE is -45.92%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.